Drug discovery jobs: science, engineering and data roles
8,944 open roles at 379 drug discovery companies in 66 countries: Clinical, regulatory and drug development (1,955), Product, operations and leadership (1,443), Process and manufacturing engineering (1,313), Research science (1,311). 8,822 of them are open to candidates of any nationality; the rest ask for citizenship or a government security check. 906 mention relocation support.
lilly.com · HQ: Indianapolis, United States · Oncology Therapeutics · Cardiometabolic Therapeutics · Prescription Drugs · 5000+ employees · Est. 1876 · Trust B · Hiring 502, 101 new
HQ: Indianapolis, United States · Oncology Therapeutics · Cardiometabolic Therapeutics · Prescription Drugs · 5000+ employees · Est. 1876 · Trust B · Hiring 502, 101 new
Eli Lilly and Company, known as Lilly, is an American pharmaceutical company headquartered in Indianapolis, Indiana, that discovers, develops and manufactures medicines for diabetes, obesity, cancer, immunology and neuroscience. Founded in 1876 by pharmacist Eli Lilly, it employs more than 50,000 people, sells its products in about 125 countries and runs manufacturing and research sites in places such as Limerick, Cork, Alcobendas, Concord and Kobe. Its openings span pharmaceutical sales territory managers, formulation operators, software engineers and AI architects, finance and marketing staff, and a large programme of interns and apprentices.
sanofi.com · HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 692, 111 new
HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 692, 111 new
Sanofi is a French pharmaceutical company formed in 1973 and assembled over five decades through a long series of mergers including Synthelabo, Aventis and Genzyme. It is now built around immunology and rare disease, with Dupixent for atopic dermatitis and asthma as by far its largest product, alongside a substantial vaccines division covering influenza, meningitis and the respiratory syncytial virus antibody Beyfortus. Headquartered in Paris, the group has sharpened its focus in recent years by separating its consumer healthcare business into the standalone company Opella and directing research spending toward biologics and immune science.
Roche is a Swiss healthcare group founded in Basel in 1896 and is unusual in operating two large divisions of comparable importance: prescription medicines and in vitro diagnostics. The pharmaceutical business is built on oncology, neurology, immunology, ophthalmology and haemophilia, with products such as Ocrevus, Hemlibra, Perjeta and Vabysmo, while the diagnostics division supplies laboratory analysers, molecular tests and sequencing systems to hospitals worldwide. The group owns the American biotechnology company Genentech outright and the Japanese firm Chugai in majority, is controlled by a family shareholder pool, and spends among the largest research budgets in the industry.
Novartis is a Swiss pharmaceutical company created in 1996 by the merger of Ciba-Geigy and Sandoz, two Basel chemical and drug houses with roots in the nineteenth century. It has spent the past decade narrowing itself into a pure innovative medicines business, spinning off its generics arm as Sandoz in 2023 and its eye care business as Alcon in 2019, and now concentrates on cardiovascular, immunology, neuroscience and oncology, including radioligand therapies and gene therapy. Headquartered in Basel and listed in Zurich and New York, it is among the largest research spenders in the industry.
csl.com · HQ: Melbourne, Australia · Vaccines · Biologics & Biosimilars · 5000+ employees · Est. 1916 · Trust B · Hiring 143, 17 new
HQ: Melbourne, Australia · Vaccines · Biologics & Biosimilars · 5000+ employees · Est. 1916 · Trust B · Hiring 143, 17 new
CSL Limited is a global biotechnology and biopharmaceutical enterprise specializing in lifesaving medicines and public health solutions. The company focuses on researching, developing, and manufacturing plasma-derived therapies, influenza vaccines, recombinant proteins, and treatments for iron deficiency and nephrology conditions through its operating divisions - CSL Behring, CSL Seqirus, and CSL Vifor. Headquartered in Melbourne, Australia, it maintains extensive research, manufacturing, and donor collection networks to deliver specialized biological therapies and vaccines to patients in over 100 countries worldwide.
adarx.com · HQ: San Diego, United States · Drug Discovery · 51-200 employees · Est. 2019 · NASDAQ: ADRX · Hiring 6, 1 new
HQ: San Diego, United States · Drug Discovery · 51-200 employees · Est. 2019 · NASDAQ: ADRX · Hiring 6, 1 new
Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Learn more about our next-generation research technologies.
Companies whose main business is biotechnology, drug discovery and development, cell and gene therapy, genomics, contract research and manufacturing (CRO, CDMO) or life science tools - and every role whose title names biotech work at any employer. Their sales, finance and office roles are left out: these pages list the science, engineering, data and IT roles.
How fresh is this?
Every role is re-checked on the employer's own careers board at least every 48 hours, and the page is rebuilt every night.
Amgen
AbbVie
Roche
AstraZeneca
GSK
Takeda Pharmaceutical
Eli Lilly and Company
Merck & Co.
Sanofi
Novartis
Regeneron Pharmaceuticals
Bristol Myers Squibb
WuXi AppTec
Moderna
Gilead Sciences
